Lumen Technologies (LUMN) had the highest return between July 10, 2024 and August 28, 2024 by a mid-cap US stock, returning 404.7%.
| ASSET | DATE | % RETURN |
|---|---|---|
Lumen Technologies (LUMN) | 7/10/2024 - 8/28/2024 | 404.72% |
CommScope (COMM) | 7/10/2024 - 8/28/2024 | 236.8% |
Regencell Bioscience (RGC) | 7/10/2024 - 8/28/2024 | 130.13% |
Upstart Holdings (UPST) | 7/10/2024 - 8/28/2024 | 70.78% |
Trupanion (TRUP) | 7/10/2024 - 8/28/2024 | 66.61% |
Xometry (XMTR) | 7/10/2024 - 8/28/2024 | 65% |
Verona Pharma PLC ADR (VRNA) | 7/10/2024 - 8/28/2024 | 57.74% |
Sunrun (RUN) | 7/10/2024 - 8/28/2024 | 53.85% |
Clear Secure (YOU) | 7/10/2024 - 8/28/2024 | 50.76% |
Goosehead Insurance (GSHD) | 7/10/2024 - 8/28/2024 | 50.35% |
Compass (COMP) | 7/10/2024 - 8/28/2024 | 47.83% |
Zeta Global (ZETA) | 7/10/2024 - 8/28/2024 | 47.77% |
Veracyte (VCYT) | 7/10/2024 - 8/28/2024 | 45.71% |
Power Solutions International, Inc Common Stock (PSIX) | 7/10/2024 - 8/28/2024 | 45.56% |
Cellebrite DI (CLBT) | 7/10/2024 - 8/28/2024 | 45.51% |
Planet Labs PBC (PL) | 7/10/2024 - 8/28/2024 | 43.43% |
Perimeter Solutions (PRM) | 7/10/2024 - 8/28/2024 | 42.84% |
Frontdoor (FTDR) | 7/10/2024 - 8/28/2024 | 42.76% |
ADMA Biologics (ADMA) | 7/10/2024 - 8/28/2024 | 42.36% |
VF (VFC) | 7/10/2024 - 8/28/2024 | 39.53% |
Mohawk Industries (MHK) | 7/10/2024 - 8/28/2024 | 39.29% |
Green Brick Partners (GRBK) | 7/10/2024 - 8/28/2024 | 39.24% |
Ocular Therapeutix (OCUL) | 7/10/2024 - 8/28/2024 | 38.95% |
Inspire Medical Systems (INSP) | 7/10/2024 - 8/28/2024 | 38.85% |
EXACT Sciences (EXAS) | 7/10/2024 - 8/28/2024 | 38.66% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.
